COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study - Quiz - MDSpire

COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study

  • By

  • Quincy Hofsink

  • Birgit I Lissenberg-Witte

  • Sabine Haggenburg

  • Abraham Goorhuis

  • Mette D Hazenberg

  • Caroline E Rutten

  • Paul den Tex

  • Elisabeth G E de Vries

  • Astrid A M van der Veldt

  • Jeanet M Kemmeren

  • Nicolette F de Keizer

  • Peter C Huijgens

  • Avinash G Dinmohamed

  • Annika van Roon

  • Joyce Pijpers

  • Caren van Roekel

  • Susan van den Hof

  • Susan J M Hahné

  • Brechje de Gier

  • Jarom Heijmans

  • Inger S Nijhof

  • October 14, 2025

  • 0 min

Share

Original Source(s)

COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study

  • by Quincy Hofsink, Birgit I Lissenberg-Witte, Sabine Haggenburg, Abraham Goorhuis, Mette D Hazenberg, Caroline E Rutten, Paul den Tex, Elisabeth G E de Vries, Astrid A M van der Veldt, Jeanet M Kemmeren, Nicolette F de Keizer, Peter C Huijgens, Avinash G Dinmohamed, Annika van Roon, Joyce Pijpers, Caren van Roekel, Susan van den Hof, Susan J M Hahné, Brechje de Gier, Jarom Heijmans, Inger S Nijhof

  • October 14, 2025

Related Content

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study